NEW YORK, NY / ACCESSWIRE / April 12, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided.
Corcept Therapeutics Incorporated (CORT)
Class Period: August 2, 2017 - February 5, 2019
Lead Plaintiff Deadline : May 13, 2019
Join the action: https://www.zlk.com/pslra-1/corcept-therapeutics-incorporated-loss-form?prid=1067&wire=1
Allegations: Corcept Therapeutics Incorporated made materially false and/or misleading statements throughout the class period and/or failed to disclose that: (1) the Company had improperly paid doctors to promote its drug Korlym; (2) the Company aggressively promoted Korlym for off-label uses; (3) the Company's sole specialty pharmacy was a related party; (4) the Company artificially inflated its revenue and sales using illicit sales practices through a related party; (5) such practices are reasonably likely to lead to regulatory scrutiny; and (6) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
To learn more about the Corcept Therapeutics Incorporated class action contact email@example.com.
Molson Coors Brewing Company (TAP)
Class Period: February 14, 2017 - February 12, 2019
Lead Plaintiff Deadline : April 16, 2019
Join the action: https://www.zlk.com/pslra-1/molson-coors-brewing-company-loss-form?prid=1067&wire=1
Allegations: Molson Coors Brewing Company made materially false and/or misleading statements and/or failed to disclose that: (1) Molson Coors failed to properly reconcile the outside basis deferred income tax liability for Molson Coors' investment in its MillerCoors, LLC partnership; (2) consequently, Molson Coors misreported net income in its consolidated financial statements for the fiscal years ending December 31, 2016 and December 31, 2017, resulting in an overall downward revision to net income; (3) Molson Coors lacked adequate internal controls over financial reporting; and (4) as a result, defendants' statements about Molson Coors' business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
To learn more about the Molson Coors Brewing Company class action contact firstname.lastname@example.org.
Inogen, Inc. (INGN)
Class Period: November 8, 2017 - February 26, 2019
Lead Plaintiff Deadline : May 6, 2019
Join the action: https://www.zlk.com/pslra-1/inogen-inc-loss-form?prid=1067&wire=1
Allegations: During the class period, Inogen, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Inogen had overstated the true size of the total addressable market ("TAM") for its portable oxygen concentrators and had misstated the basis for its calculation of the TAM; (ii) Inogen had falsely attributed its sales growth to the strong sales acumen of its salesforce, when in reality it was due in large part to sales tactics designed to deceive its elderly customer base; (iii) the growth in Inogen's domestic business-to-business sales to home medical equipment ("HME") providers was inflated, unsustainable and was eroding direct-to-consumer sales; and (iv) very little of Inogen's business was actually coming from the more stable Medicare market.
To learn more about the Inogen, Inc. class action contact email@example.com.
You have until the lead plaintiff deadlines to request the court appoint as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
SOURCE: Levi & Korsinsky, LLP
View source version on accesswire.com: